BridgeMD
Tests treatment safety and results for Hiv
Official title Effectiveness of Gut Microbiota-targeted Diatery Intervention Among Older People Living With HIV
ClinicalTrials.gov ID: NCT06560840
What this study is testing
- What it's testing
- The goal of this clinical trial is to conduct a dietary intervention targeting HIV specific gut microbiota alterations for primary atherosclerotic cardiovascular disease (ASCVD) prevention and evaluate its effectiveness in preventing ASCVD among older people living with HIV (PLWH).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- HIV-infected patients diagnosed according to the diagnostic criteria of China AIDS diagnosis and treatment guidelines;
- Aged 40 years and above;
- at risk of CVD: having any two of those risk factors: dyslipidemia, DM or elevated blood glucose, smoking, hypertention or elevated blood pressure...
- Those with a predicted survival time of \>1 year;
- No plans to leave the depth in the next 3 months;
You likely can't join if
- Those with a previous history of CVD;
- Those with HIV-related neurocognitive impairment, Alzheimer's disease or dementia, and a variety of serious opportunistic infections;
- Currently suffering from malignant tumors, gastrointestinal diseases; People with an aversion to eating;
- Allergic to nuts and fish;
- People who take medicinal calcium \>1000 mg per day or omega-3 supplements;
- Plan to become pregnant within 6 months;
See the full eligibility criteria
- HIV-infected patients diagnosed according to the diagnostic criteria of China AIDS diagnosis and treatment guidelines;
- Aged 40 years and above;
- at risk of CVD: having any two of those risk factors: dyslipidemia, DM or elevated blood glucose, smoking, hypertention or elevated blood pressure, metabolic syndrome,overweight/obesity; or PCE score\>5%,
- Those with a predicted survival time of \>1 year;
- No plans to leave the depth in the next 3 months;
- Voluntary participation in this study and signing the informed consent
- Those with a previous history of CVD;
- Those with HIV-related neurocognitive impairment, Alzheimer's disease or dementia, and a variety of serious opportunistic infections;
- Currently suffering from malignant tumors, gastrointestinal diseases; People with an aversion to eating;
- Allergic to nuts and fish;
- People who take medicinal calcium \>1000 mg per day or omega-3 supplements;
- Plan to become pregnant within 6 months;
- Are participating in other HIV-related or dietary intervention-related scientific research programs.
The study team makes the final eligibility decision.
Where it's taking place
- Shenzhen, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shenzhen, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.